Smoke-free New Zealand 2025 – utopia or a model?
Authors:
Eva Králíková
Authors place of work:
Ústav hygieny a epidemiologie 1. LF UK a VFN a Centrum pro závislé na tabáku III. interní kliniky – kliniky endokrinologie a metabolismu 1. LF UK a VFN, Praha
1
Published in the journal:
Čas. Lék. čes. 2012; 151: 257-258
Category:
Special Articles
Summary
New Zealand politicians are aware of the devastating economic and health impact of smoking in their country. The prevalence of that dependence is in New Zealand population aged 15 to 64 years about 20%, but only 4% of the population are “happy” smokers. Therefore, the majority of the population, including smokers, should support plan of gradual effective steps, leading in 2025 to “smoke-free” New Zealand with smoking prevalence in the population below 5%. In the same age group, according to the National Institute of Public Health, the Czech smoking prevalence has remained about 30% for almost ten years and no effective tobacco control legislation is in sight.
Key words:
New Zealand smoke-free, tobacco control.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Czech paediatric cardiac surgery – history and presence
- Addition of statins into the public water supply? Risks of side effects and low cholesterol levels
- Long-term therapy of idiopathic inflammatory bowel disease
- Physician and freedom of conscience